Literature DB >> 27921171

Computed tomography and magnetic resonance fusion imaging in cholesteatoma preoperative assessment.

Agustín Campos1, Federico Mata2,3, Rosa Reboll4, María Luisa Peris2, Jorge Basterra4.   

Abstract

The purpose of this study is to describe a method for developing fusion imaging for the preoperative evaluation of cholesteatoma. In 33 patients diagnosed with cholesteatoma, a high-resolution temporal bone computed tomography (CT) scan without intravenous contrast and propeller diffusion-weighted magnetic resonance imaging (MRI) were performed. Both studies were then sent to the BrainLAB work station, where the images were fused to obtain a morphological and color map. Intraoperative findings coincided with fusion CT-MRI imaging in all but two patients. In addition, one false positive and one false negative case were observed. CT and diffusion-weighted MRI are complementary techniques that should be employed to assess a cholesteatoma prior to surgery in many cases. Hence, to combine the advantages of each technique, we developed a fusion image technique similar to those that are routinely employed for radiotherapy planning and positron emission tomography-CT imaging. Fusion images can prove useful in selected cases.

Entities:  

Keywords:  Cholesteatoma; Computed tomography; Fusion; Magnetic resonance

Mesh:

Year:  2016        PMID: 27921171     DOI: 10.1007/s00405-016-4415-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

Review 1.  Diffusion-weighted magnetic resonance imaging of the temporal bone.

Authors:  B De Foer; J-P Vercruysse; M Spaepen; T Somers; M Pouillon; E Offeciers; J W Casselman
Journal:  Neuroradiology       Date:  2010-07-15       Impact factor: 2.804

Review 2.  Technical aspects of MR diffusion imaging of the body.

Authors:  Olaf Dietrich; Andreas Biffar; Andrea Baur-Melnyk; Maximilian F Reiser
Journal:  Eur J Radiol       Date:  2010-03-29       Impact factor: 3.528

3.  The role of preoperative CT scan in patients with chronic otitis media.

Authors:  Firas Q Alzoubi; Haitham A Odat; Hassan A Al-Balas; S R Saeed
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-18       Impact factor: 2.503

4.  The ongoing dilemma of residual cholesteatoma detection: are current magnetic resonance imaging techniques good enough?

Authors:  M P A Clark; B D Westerberg; D M Fenton
Journal:  J Laryngol Otol       Date:  2010-03-05       Impact factor: 1.469

5.  High-resolution three-dimensional diffusion-weighted MRI/CT image data fusion for cholesteatoma surgical planning: a feasibility study.

Authors:  Koji Yamashita; Akio Hiwatashi; Osamu Togao; Kazufumi Kikuchi; Nozomu Matsumoto; Makoto Obara; Takashi Yoshiura; Hiroshi Honda
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-28       Impact factor: 2.503

6.  The role of diffusion-weighted magnetic resonance imaging in cholesteatoma diagnosis and follow-up. Study with the diffusion PROPELLER technique.

Authors:  Manuel Mateos-Fernández; Fernando Mas-Estellés; Carlos de Paula-Vernetta; Abel Guzmán-Calvete; Ricardo Villanueva-Martí; Constantino Morera-Pérez
Journal:  Acta Otorrinolaringol Esp       Date:  2012-10-23

7.  Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma.

Authors:  Lela Migirov; Michael Wolf; Gahl Greenberg; Ana Eyal
Journal:  Otol Neurotol       Date:  2014-01       Impact factor: 2.311

8.  Non echo planar, diffusion-weighted magnetic resonance imaging (periodically rotated overlapping parallel lines with enhanced reconstruction sequence) compared with echo planar imaging for the detection of middle-ear cholesteatoma.

Authors:  A V Kasbekar; D J Scoffings; B Kenway; J Cross; N Donnelly; S W K Lloyd; D Moffat; P R Axon
Journal:  J Laryngol Otol       Date:  2010-11-29       Impact factor: 1.469

9.  Fusion of MRIs and CT scans for surgical treatment of cholesteatoma of the middle ear in children.

Authors:  Isabelle Plouin-Gaudon; Denis Bossard; Sonia Ayari-Khalfallah; Patrick Froehlich
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-09

10.  Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience.

Authors:  Anca-Ligia Grosu; Rainer Lachner; Nicole Wiedenmann; Sibylle Stärk; Reinhard Thamm; Peter Kneschaurek; Markus Schwaiger; Michael Molls; Wolfgang A Weber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

View more
  5 in total

1.  Utility of diffusion-weighted magnetic resonance imaging in the diagnosis of cholesteatoma and the influence of the learning curve.

Authors:  Leire Garcia-Iza; Amaia Guisasola; Ane Ugarte; Juan Jose Navarro; Miren Goiburu; Xabier Altuna
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-28       Impact factor: 2.503

2.  Improved Assessment of Middle Ear Recurrent Cholesteatomas Using a Fusion of Conventional CT and Non-EPI-DWI MRI.

Authors:  F Felici; U Scemama; D Bendahan; J-P Lavieille; G Moulin; C Chagnaud; M Montava; A Varoquaux
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-14       Impact factor: 3.825

3.  Comparison of the Utility of High-Resolution CT-DWI and T2WI-DWI Fusion Images for the Localization of Cholesteatoma.

Authors:  X Fan; C Ding; Z Liu
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-02       Impact factor: 4.966

4.  High-resolution computed tomography (HRCT) in pediatric and adult patients with unsafe chronic suppurative otitis media (CSOM) and its surgical correlation.

Authors:  Ramandeep Singh; Rubal Rai; Paramdeep Singh; Sanjay Sethi; Amrit Pal Singh Ahluwalia; Gagandeep Choudhary
Journal:  J Family Med Prim Care       Date:  2020-08-25

5.  The Role of Fusion Technique of Computed Tomography and Non-echo-planar Diffusion-weighted Imaging in the Evaluation of Surgical Cholesteatoma Localization.

Authors:  Ayse Ozlem Balik; Lutfu Seneldir; Aysegul Verim; Sema Zer Toros
Journal:  Medeni Med J       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.